Choksi Laboratories Ltd
Choksi Laboratories Ltd (CHOKSILA) last traded at ₹144, a market capitalisation of ₹100 crore, on a P/E of 52.7. Over the past 52 weeks the stock has ranged between ₹81.8 and ₹229. Choksi Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹12.06 crore and net profit of ₹0.58 crore. Choksi Laboratories Ltd’s annual general meeting is scheduled for 18 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Choksi Laboratories Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Choksi Laboratories Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹12.06 cr, up 7.3% from ₹11.24 cr a year earlier. Net profit was ₹0.58 cr, up 48.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 9.26 | 10.38 | 11.4 | 11.24 | 11.12 | 10.82 | 12.82 | 12.06 |
| Expenses | 6.9 | 7.84 | 7.9 | 8.34 | 8.19 | 8.16 | 9.18 | 8.78 |
| Operating profit | 2.36 | 2.54 | 3.5 | 2.9 | 2.93 | 2.66 | 3.64 | 3.28 |
| OPM % | 25.49% | 24.47% | 30.70% | 25.80% | 26.35% | 24.58% | 28.39% | 27.20% |
| Other income | 0.01 | 0.01 | 0.04 | 0 | 0.01 | 0.89 | 0.06 | 0.02 |
| Interest | 0.66 | 0.69 | 0.58 | 0.6 | 0.69 | 0.81 | 0.71 | 0.73 |
| Depreciation | 1.61 | 1.68 | 1.7 | 1.68 | 1.69 | 1.83 | 1.89 | 1.97 |
| Profit before tax | 0.1 | 0.18 | 1.26 | 0.62 | 0.56 | 0.91 | 1.1 | 0.6 |
| Tax % | 20.00% | 44.44% | 26.98% | 38.71% | 57.14% | 64.84% | 6.36% | 3.33% |
| Net profit | 0.08 | 0.11 | 0.92 | 0.39 | 0.24 | 0.31 | 1.03 | 0.58 |
| EPS (₹) | 0.11 | 0.16 | 1.32 | 0.56 | 0.34 | 0.45 | 1.48 | 0.83 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Choksi Laboratories Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 25.69 | 30.04 | 34.44 | 36.7 | 41.78 | 46.01 | 46.82 |
| Operating profit | 4.12 | 8.9 | 10.27 | 10.28 | 11.3 | 12.13 | 12.51 |
| OPM % | 16.04% | 29.63% | 29.82% | 28.01% | 27.05% | 26.36% | 26.72% |
| Net profit | -2.61 | 0.21 | 3.21 | 1.11 | 1.52 | 1.96 | 2.16 |
| EPS (₹) | -3.75 | 0.30 | 4.61 | 1.59 | 2.18 | 2.81 | 3.10 |
TTM is the trailing twelve months to the most recent quarter.
Choksi Laboratories Ltd growth and returns
- 10 Years
- 6%
- 5 Years
- 12%
- 3 Years
- 10%
- TTM
- 11%
- 10 Years
- 7%
- 5 Years
- 21%
- 3 Years
- -3%
- TTM
- 27%
- 10 Years
- 27%
- 5 Years
- 53%
- 3 Years
- 37%
- 1 Year
- -39%
- 10 Years
- 3%
- 5 Years
- 6%
- 3 Years
- 6%
- Last Year
- 6%
Choksi Laboratories Ltd shareholding pattern
Promoters held 31.48% at Jun 2026, broadly unchanged since Jun 2025. FIIs 7.02%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% |
| FIIs | 0.00% | 0.00% | 1.94% | 4.31% | 5.69% | 5.69% | 6.03% | 7.02% |
| Public | 68.52% | 68.52% | 66.58% | 64.22% | 62.83% | 62.83% | 62.49% | 61.49% |
| No. of shareholders | 4,334 | 4,466 | 4,162 | 4,167 | 4,067 | 4,057 | 4,011 | 3,945 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Choksi Laboratories Ltd’s AGM?
Choksi Laboratories Ltd’s annual general meeting is scheduled for 18 Sept 2026.
- AGM33rd Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Choksi Laboratories Ltd corporate filings
- Submission of Annual Report for the F.Y. 2025-26Otherslow impact
Cruxal's analysis: Choksi Laboratories Ltd has submitted its Annual Report for the fiscal year 2025-26 as…
Read the full analysis - Submission of Notice convening 33rd AGM of the company to be held on 18th September, 2026 at 12:30 p.m. through Video conference/Other Audio Visual meansAGM/EGMlow impact
Cruxal's analysis: Choksi Laboratories Limited has issued the formal notice for its 33rd Annual General…
Read the full analysis - Intimation under Regulation 30 of SEBI (LODR) 2015 for inspection of USFDACompany Updatemedium impact
Cruxal's analysis: Choksi Laboratories has provided an intimation under Regulation 30 of SEBI (LODR) 2015…
Read the full analysis - Submission of newspaper clipping of information regarding 33rd Annual General Meeting of the companyCompany Updatelow impact
Cruxal's analysis: Choksi Laboratories Ltd has submitted the required newspaper clippings regarding the…
Read the full analysis - Newspaper publication of unaudited financial result for the quarter ended 30th June, 2026Company Updatelow impact
Cruxal's analysis: Choksi Laboratories Limited has released its unaudited financial results for the quarter…
Read the full analysis - Reappointment of Internal Auditor for the F.Y. 2026-27Company Updatelow impact
Cruxal's analysis: Choksi Laboratories Limited has formally disclosed the re-appointment of M/s Tanmay V…
Read the full analysis - Reappointment of Ms. Himika Choksi as Whole Time Director for further period of five year w.e.f 01.04.2027 subject to approval from shareholders in the ensuing AGM.Company Updatelow impact
Cruxal's analysis: Choksi Laboratories Limited has formally announced the re-appointment of Ms. Himika…
Read the full analysis - Considered and approved the unaudited financial results of the company for the quarter ended 30th June. 2026Resultmedium impact
Cruxal's analysis: Choksi Laboratories Limited reported revenue from operations of 12.06 crore for the…
Read the full analysis - 1. Considered and approved the Unaudited Financial Results for the Quarter ended on 30th June, 2026 along with the Limited review report; 2. Decided the date for closure of Register of ....Board Meetinghigh impact
Cruxal's analysis: Choksi Laboratories Limited reported a steady performance for the quarter ended 30th June…
Read the full analysis - Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. To consider and approve ....Board Meetinglow impact
Cruxal's analysis: Choksi Laboratories Limited has formally intimated the BSE regarding a Board of Directors…
Read the full analysis - Newspaper publication of information regarding change of RTACompany Updatelow impact
Cruxal's analysis: Choksi Laboratories Ltd has informed the exchange about the newspaper publication of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Choksi Laboratories Ltd
Cruxal reads every Choksi Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.